Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 CAD | 0.00% | -12.00% | -21.43% |
May. 03 | PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy | MT |
Apr. 23 | Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla | CI |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Engineering-grade (Non-GMP) Product
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +581.44% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +581.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nick Kadysh
CEO | Chief Executive Officer | 38 | 21-03-20 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | 21-03-21 |
Harpreet Kaur
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shane Morris
COO | Chief Operating Officer | 49 | 21-03-21 |
David Purcell
SAM | Sales & Marketing | - | 22-03-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Roy
BRD | Director/Board Member | - | 22-06-03 |
Director/Board Member | 62 | 21-03-20 | |
Jodi Butts
CHM | Chairman | 51 | 21-03-20 |
Nick Kadysh
CEO | Chief Executive Officer | 38 | 21-03-20 |
Perry Tsergas
BRD | Director/Board Member | 39 | 21-03-20 |
Fraser MacDonald
BRD | Director/Board Member | 38 | 21-03-20 |
Harriet de Wit
BRD | Director/Board Member | 76 | 21-03-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 91,124,217 | 85,873,717 ( 94.24 %) | 0 | 94.24 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-21.43% | 7.01M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- MDMA Stock
- Company Pharmala Biotech Holdings Inc.